Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Rezolute, Inc. (RZLT)

Autolus Therapeutics PLC Sponsored ADR and Rezolute, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Rezolute, Inc. are of similar size ($481.8M and $471.1M). Rezolute, Inc. has the higher net margin (0.00% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Rezolute, Inc. leads on 10 and Autolus Therapeutics PLC Sponsored ADR on 3.

Valuation

Metric AUTL RZLT Biotechnology median
P/E n/m n/m 8.56
P/S 3.95 n/m 10.17
P/B 6.19 5.04 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 2.88 n/m 9.64
Earnings yield (60.92%) (15.57%) (29.41%)
Free cash flow yield (54.82%) (12.90%) (23.50%)

Profitability

Metric AUTL RZLT Biotechnology median
Gross margin 15.66% 0.00% 65.16%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (59.04%) (56.66%)
Return on assets (46.15%) (53.82%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL RZLT Biotechnology median
Revenue growth (TTM) 193.29% — 5.64%
EPS growth (last fiscal year) (25.58%) 23.47% 30.08%
Revenue growth, 5-year CAGR 113.11% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL RZLT Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 9.68 4.72
Net debt to EBITDA 1.16 1.26 0.96

Dividend

Metric AUTL RZLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AUTL RZLT Biotechnology median
Market cap 481.75m 471.07m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack